Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin) Treatment and Impact on Quality of Life.

Trial Profile

Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin) Treatment and Impact on Quality of Life.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Jun 2014

At a glance

  • Drugs Pramipexole (Primary)
  • Indications Parkinson's disease; Tremor
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 31 Aug 2010 Additional locations identified as reported by ClinicalTrials.gov.
    • 09 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top